Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1996 1
1997 1
1998 1
1999 3
2000 3
2003 3
2006 2
2007 1
2010 1
2011 6
2012 7
2013 10
2014 3
2015 6
2016 4
2017 2
2018 15
2019 12
2020 20
2021 14
Text availability
Article attribute
Article type
Publication date

Search Results

103 results
Results by year
Filters applied: . Clear all
Page 1
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial.
Khalaf DJ, Annala M, Taavitsainen S, Finch DL, Oja C, Vergidis J, Zulfiqar M, Sunderland K, Azad AA, Kollmannsberger CK, Eigl BJ, Noonan K, Wadhwa D, Attwell A, Keith B, Ellard SL, Le L, Gleave ME, Wyatt AW, Chi KN. Khalaf DJ, et al. Among authors: zulfiqar m. Lancet Oncol. 2019 Dec;20(12):1730-1739. doi: 10.1016/S1470-2045(19)30688-6. Epub 2019 Nov 11. Lancet Oncol. 2019. PMID: 31727538 Clinical Trial.
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer.
Annala M, Vandekerkhove G, Khalaf D, Taavitsainen S, Beja K, Warner EW, Sunderland K, Kollmannsberger C, Eigl BJ, Finch D, Oja CD, Vergidis J, Zulfiqar M, Azad AA, Nykter M, Gleave ME, Wyatt AW, Chi KN. Annala M, et al. Among authors: zulfiqar m. Cancer Discov. 2018 Apr;8(4):444-457. doi: 10.1158/2159-8290.CD-17-0937. Epub 2018 Jan 24. Cancer Discov. 2018. PMID: 29367197 Free article. Clinical Trial.
Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial.
Khalaf DJ, Sunderland K, Eigl BJ, Kollmannsberger CK, Ivanov N, Finch DL, Oja C, Vergidis J, Zulfiqar M, Gleave ME, Chi KN. Khalaf DJ, et al. Among authors: zulfiqar m. Eur Urol. 2019 Jun;75(6):940-947. doi: 10.1016/j.eururo.2018.12.015. Epub 2018 Dec 24. Eur Urol. 2019. PMID: 30591354 Clinical Trial.
2-(6-Meth-oxy-naphthalen-2-yl)-1-(morpholin-4-yl)propan-1-one.
Nasirullah, Islam NU, Tahir MN, Khan I, Zulfiqar M. Nasirullah, et al. Among authors: zulfiqar m. Acta Crystallogr Sect E Struct Rep Online. 2012 Sep 1;68(Pt 9):o2636. doi: 10.1107/S1600536812034083. Epub 2012 Aug 4. Acta Crystallogr Sect E Struct Rep Online. 2012. PMID: 22969536 Free PMC article.
Imaging of Renal Infections and Inflammatory Disease.
Zulfiqar M, Ubilla CV, Nicola R, Menias CO. Zulfiqar M, et al. Radiol Clin North Am. 2020 Sep;58(5):909-923. doi: 10.1016/j.rcl.2020.05.004. Epub 2020 Jul 14. Radiol Clin North Am. 2020. PMID: 32792123 Review.
Krukenberg Tumors: Update on Imaging and Clinical Features.
Zulfiqar M, Koen J, Nougaret S, Bolan C, VanBuren W, McGettigan M, Menias C. Zulfiqar M, et al. AJR Am J Roentgenol. 2020 Oct;215(4):1020-1029. doi: 10.2214/AJR.19.22184. Epub 2020 Jul 13. AJR Am J Roentgenol. 2020. PMID: 32755184 Review.
Abdominal Imaging Manifestations of Recreational Drug Use.
Mansour J, Zulfiqar M, Umer A, Zurcher KS, Heeger A, Menias CO. Mansour J, et al. Among authors: zulfiqar m. Radiographics. 2020 Nov-Dec;40(7):1895-1915. doi: 10.1148/rg.2020200048. Epub 2020 Oct 16. Radiographics. 2020. PMID: 33064622 Review.
103 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page